ITFRF yields 5.03% · PFE yields 6.13%● Live data
📍 ITFRF pulled ahead of the other in Year 1
Combined, ITFRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ITFRF + PFE for your $10,000?
ITFOR Inc. provides support services for the implementation of information technology in Japan. It develops solutions comprising consulting, system configuration, customer specific solution development, operation, and management for network security. The company also offers financial solution systems, such as credit collection, loan assessment management, scoring, collecting, tele-marketing, and local governments systems; CTI systems that offer call-center productivity enhancements; consultation and installation of open platform for retail service customers; and e-commerce systems. In addition, it provides network systems, including corporate infrastructure network, backbone network consultation and design, IP services, edge solutions for telecom carriers, network security solutions, and personal information management; and professional and consultation services, as well as customer services. The company was formerly known as CJK Co. Ltd. and changed its name to ITFOR Inc. in 2000. ITFOR Inc. was founded in 1972 and is headquartered in Tokyo, Japan.
Full ITFRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.